Prostate cancer: screening, diagnosis and management in 2007.

Prostate cancer is the most common solid malignancy in men. Screening with PSA and DRE has led to an increased incidence of the disease, but has also contributed to decreasing mortality. Improved technology has led to treatments focused on maintaining cancer cure rates while minimizing the effect of prostate cancer treatment on quality of life. Recently, docetaxel has been added to standard androgen ablation as an effective treatment for advanced prostate cancer.